Complete Filing Data
ANAPTYSBIO, INC reported Stockholders Equity of $37.21 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ANAPTYSBIO, INC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $234.6M | $91.3M | $17.2M | $10.3M | $63.2M | $75.0M | $8.0M | $5.0M | $10.0M | $16.7M | $17.6M |
| Net Income Loss | -$13.2M | -$145.2M | -$163.6M | -$128.7M | -$57.8M | -$19.9M | -$97.3M | -$61.7M | -$30.1M | -$4.3M | -$5.4M |
| Operating Income Loss | $47.9M | -$114.9M | -$164.4M | -$115.2M | -$56.8M | -$23.9M | -$107.4M | -$66.7M | -$28.8M | -$3.0M | -$3.3M |
| Operating Expenses | $186.7M | $206.2M | $181.6M | $125.4M | $120.0M | $98.9M | $115.4M | $71.7M | $38.8M | $19.7M | $20.9M |
| Nonoperating Income Expense | -$61.0M | -$30.3M | $788.0K | -$13.5M | -$982.0K | $3.9M | $9.9M | $4.9M | -$1.3M | -$1.2M | -$1.9M |
| General And Administrative Expense | $50.7M | $42.4M | $41.9M | $36.6M | $21.5M | $18.9M | $16.1M | $15.5M | $9.3M | $4.3M | $3.6M |
| Comprehensive Income Net Of Tax | -$13.6M | -$144.1M | -$159.2M | -$133.5M | -$58.2M | -$20.3M | -$96.8M | -$61.5M | -$30.5M | -$4.3M | -$5.4M |
| Other Nonoperating Income Expense | $5.4M | $14.0K | -$2.0K | $12.0K | $37.0K | -$11.0K | $1.0K | -$159.0K | $229.0K | -$147.0K | -$225.0K |
| Research And Development Expense | $88.8M | $98.5M | $80.0M | $99.3M | $56.2M | $29.4M | $15.4M | $17.3M | |||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$329.0K | $1.1M | $4.4M | -$4.8M | -$418.0K | -$342.0K | $561.0K | $203.0K | -$426.0K | $0.00 | $0.00 |
| Income Tax Expense Benefit | $164.0K | $3.0K | -$4.0K | $24.0K | $0.00 | $0.00 | -$152.0K | -$192.0K | $0.00 | $0.00 | $139.0K |
| Other Comprehensive Income Loss Net Of Tax | $203.0K | -$426.0K | |||||||||
| Interest Expense | $0.00 | $0.00 | $1.0M | $1.7M | $1.8M | $458.0K | $460.0K | ||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$426.0K | $0.00 | $0.00 | ||||||||
| Noncash Advance Future Royalties Interest Expense | $79.9M | $50.1M | $18.1M | $21.1M | $1.5M | $0.00 | $0.00 | ||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$329.0K | $1.1M | $4.4M | -$4.8M | |||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$13.1M | -$145.2M | -$163.6M | -$128.7M | -$57.8M | -$19.9M | -$97.5M | -$61.8M | -$30.1M | -$4.3M | -$5.3M |
| Interest Income Expense Nonoperating Net |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $76.3M | $22.3M | $27.8M | $30.0M | $11.0M | $7.2M | $3.3M | $3.5M | $1.4M | $1.3M | $1.2M | $970.0K | $20.9M | $30.0M | $11.2M | $0.00 | $0.00 | $15.0M | $0.00 | $5.0M | $0.00 | $5.0M | $0.00 | $0.00 | $0.00 | $7.0M | $0.00 | $3.2M | $5.9M | $4.9M | ||||
| Net Income Loss | $15.1M | -$38.6M | -$39.3M | -$32.9M | -$46.7M | -$43.9M | -$37.3M | -$39.8M | -$44.3M | -$33.5M | -$32.6M | -$36.3M | -$6.7M | -$429.0K | -$18.2M | -$23.8M | -$21.5M | -$8.3M | -$31.0M | -$24.0M | -$22.1M | -$16.0M | -$13.6M | -$15.1M | -$9.1M | -$2.7M | -$11.4M | -$1.1M | $2.3M | -$888.0K | ||||
| Operating Income Loss | $34.7M | -$26.2M | -$27.5M | -$22.8M | -$40.3M | -$42.2M | -$37.7M | -$40.1M | -$44.4M | -$29.6M | -$27.8M | -$31.7M | -$6.8M | -$533.0K | -$18.4M | -$24.3M | -$22.6M | -$10.3M | -$22.3M | -$33.7M | -$26.7M | -$24.8M | -$19.7M | -$16.9M | -$14.4M | -$15.8M | -$7.2M | -$9.1M | -$2.6M | -$10.0M | -$3.2M | -$1.1M | $2.4M | -$1.1M |
| Operating Expenses | $41.6M | $48.4M | $55.3M | $52.8M | $51.3M | $49.4M | $41.1M | $43.6M | $45.8M | $30.9M | $29.0M | $32.7M | $27.7M | $30.6M | $29.6M | $24.3M | $22.6M | $25.3M | $33.7M | $31.7M | $24.8M | $21.9M | $14.4M | $15.8M | $9.1M | $9.6M | $10.0M | $4.3M | $3.5M | $6.0M | ||||
| Nonoperating Income Expense | -$19.6M | -$12.4M | -$11.7M | -$10.1M | -$6.3M | -$1.7M | $424.0K | $298.0K | $146.0K | -$3.9M | -$4.8M | -$4.5M | $97.0K | $104.0K | $198.0K | $569.0K | $1.1M | $2.0M | $2.7M | $2.6M | $2.7M | $929.0K | $797.0K | $671.0K | -$3.0K | -$129.0K | -$1.4M | -$40.0K | -$41.0K | $251.0K | ||||
| General And Administrative Expense | $10.2M | $10.6M | $14.1M | $10.6M | $9.3M | $12.3M | $10.2M | $10.7M | $10.8M | $8.9M | $8.2M | $10.2M | $5.4M | $5.2M | $5.4M | $4.8M | $4.7M | $4.3M | $3.8M | $4.3M | $4.1M | $4.0M | $3.8M | $3.9M | $2.4M | $2.4M | $2.1M | $1.0M | $1.2M | $1.2M | ||||
| Comprehensive Income Net Of Tax | $15.2M | -$38.8M | -$39.5M | -$31.7M | -$46.5M | -$43.8M | -$36.0M | -$40.2M | -$42.3M | -$35.6M | -$34.0M | -$38.3M | -$6.7M | -$494.0K | -$18.3M | -$24.3M | -$21.9M | -$7.5M | -$31.1M | -$23.6M | -$21.7M | -$15.8M | -$13.5M | -$15.9M | -$9.1M | -$2.7M | -$11.4M | -$1.1M | $181.0K | -$888.0K | ||||
| Other Nonoperating Income Expense | $0.00 | $3.5M | $1.9M | -$5.0K | $0.00 | -$2.0K | $1.0K | $3.0K | -$4.0K | $4.0K | $6.0K | $6.0K | $33.0K | $0.00 | $3.0K | -$56.0K | $26.0K | $94.0K | $144.0K | -$41.0K | $7.0K | -$40.0K | -$64.0K | -$63.0K | $91.0K | $29.0K | $225.0K | $72.0K | -$13.0K | |||||
| Research And Development Expense | $31.4M | $37.8M | $41.2M | $42.2M | $42.0M | $37.0M | $30.9M | $32.9M | $35.0M | $22.1M | $20.8M | $22.5M | $22.2M | $25.3M | $24.2M | $19.5M | $17.9M | $21.0M | $29.9M | $27.4M | $20.6M | $17.9M | $10.6M | $11.8M | $6.7M | $7.2M | $7.9M | $3.3M | $2.3M | $4.8M | ||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $53.0K | -$167.0K | -$144.0K | $1.2M | $209.0K | $173.0K | $1.3M | -$344.0K | $2.0M | $136.0K | $124.0K | -$801.0K | $16.0K | -$46.0K | -$13.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Income Tax Expense Benefit | $0.00 | $39.0K | $44.0K | $0.00 | $9.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$51.0K | -$60.0K | -$19.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax | $1.3M | -$344.0K | $2.0M | -$2.1M | -$1.4M | -$2.0M | -$24.0K | -$65.0K | -$107.0K | -$494.0K | -$392.0K | $807.0K | -$94.0K | $370.0K | $427.0K | $136.0K | $124.0K | -$375.0K | ||||||||||||||||
| Interest Expense | $0.00 | $0.00 | $0.00 | $240.0K | $281.0K | $320.0K | $400.0K | $436.0K | $451.0K | $452.0K | $439.0K | $428.0K | $116.0K | $116.0K | $115.0K | |||||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$24.0K | -$65.0K | -$107.0K | -$494.0K | -$392.0K | $807.0K | -$94.0K | $370.0K | $427.0K | $136.0K | $124.0K | -$801.0K | $16.0K | -$46.0K | -$13.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Noncash Advance Future Royalties Interest Expense | $22.5M | $19.6M | $18.1M | $15.4M | $11.0M | $6.3M | $4.4M | $4.4M | $4.3M | $6.1M | $5.9M | $4.9M | $0.00 | $0.00 | $0.00 | |||||||||||||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $53.0K | -$167.0K | -$144.0K | $1.2M | $209.0K | $173.0K | $1.3M | -$344.0K | $2.0M | -$2.1M | -$1.4M | -$2.0M | -$24.0K | -$65.0K | -$107.0K | |||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $15.1M | -$38.6M | -$39.3M | -$32.9M | -$46.7M | -$43.9M | -$37.3M | -$39.8M | ||||||||||||||||||||||||||
| Interest Income Expense Nonoperating Net | $64.0K | $104.0K | $195.0K | $625.0K | $1.1M | $1.9M | $2.8M | $3.0M | $3.0M | $1.4M | $1.3M | $1.2M | $358.0K | $281.0K | $122.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $37.2M | $70.9M | $88.1M | $262.1M | $356.4M | $396.7M | $405.0M | $486.4M | $307.6M | -$38.2M | -$35.2M | -$30.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $238.2M | $123.1M | $36.0M | $71.3M | $495.7M | $250.5M | $171.1M | $113.7M | $81.2M | $51.3M | $51.7M | $22.3M |
| Retained Earnings Accumulated Deficit | -$772.6M | -$759.3M | -$614.1M | -$450.5M | -$321.8M | -$264.0M | -$244.0M | -$146.7M | -$85.0M | -$54.9M | ||
| Property Plant And Equipment Net | $1.4M | $1.8M | $2.1M | $2.1M | $2.3M | $1.8M | $1.6M | $1.4M | $665.0K | $471.0K | ||
| Prepaid Expense And Other Assets Current | $4.8M | $5.7M | $9.1M | $4.5M | $4.9M | $2.9M | $3.5M | $7.0M | $2.7M | $1.6M | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Liabilities Current | $38.6M | $45.4M | $37.4M | $26.1M | $16.1M | $19.8M | $29.5M | $21.8M | $14.1M | $5.7M | ||
| Liabilities And Stockholders Equity | $364.4M | $483.8M | $452.4M | $610.4M | $643.1M | $416.6M | $435.2M | $509.0M | $329.4M | $62.2M | ||
| Common Stock Value | $28.0K | $30.0K | $27.0K | $29.0K | $28.0K | $27.0K | $27.0K | $27.0K | $24.0K | $3.0K | ||
| Cash And Cash Equivalents At Carrying Value | $238.2M | $123.1M | $36.0M | $71.3M | $495.7M | $250.5M | $171.0M | $113.6M | $81.2M | $51.2M | ||
| Available For Sale Securities Debt Securities Noncurrent | $0.00 | $35.5M | $27.0M | $142.9M | $67.1M | $17.5M | $54.3M | $73.1M | $75.9M | $0.00 | ||
| Available For Sale Securities Debt Securities Current | $73.4M | $262.3M | $354.9M | $369.9M | $52.4M | $143.2M | $203.2M | $313.5M | $167.2M | $0.00 | ||
| Assets Current | $350.3M | $431.9M | $406.8M | $447.2M | $553.9M | $396.6M | $377.7M | $434.2M | $252.7M | $58.2M | ||
| Assets | $364.4M | $483.8M | $452.4M | $610.4M | $643.1M | $416.6M | $435.2M | $509.0M | $329.4M | $62.2M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$24.0K | $305.0K | -$797.0K | -$5.2M | -$422.0K | -$4.0K | $338.0K | -$223.0K | -$426.0K | $0.00 | ||
| Accrued Liabilities Current | $32.7M | $39.5M | $31.0M | $21.6M | $12.9M | $15.3M | $11.1M | $8.8M | $4.9M | $3.4M | ||
| Accounts Payable Current | $3.9M | $4.0M | $4.7M | $2.8M | $1.7M | $4.2M | $16.2M | $5.4M | $2.3M | $2.3M | ||
| Other Assets Noncurrent | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $258.0K | $1.5M | $148.0K | $46.0K | |||
| Unrealized Gain Loss On Investments | $4.7M | $10.3M | $10.5M | $2.5M | -$493.0K | -$461.0K | $2.6M | $1.2M | -$11.0K | $0.00 | ||
| Receivables Net Current | $33.9M | $40.8M | $6.9M | $1.4M | $876.0K | $0.00 | $1.2M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $115.1M | $87.1M | -$35.3M | -$424.4M | $245.2M | $79.4M | $57.4M | $32.4M | ||||
| Operating Lease Right Of Use Asset Amortization Expense | $1.9M | $1.8M | $1.7M | $1.7M | $1.5M | $1.1M | $893.0K | |||||
| Restricted Cash And Cash Equivalents Noncurrent | $0.00 | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | ||||||
| Repayments Of Notes Payable | $0.00 | $0.00 | $1.4M | $7.5M | $6.9M | $0.00 | $0.00 | |||||
| Operating Lease Right Of Use Asset | $12.5M | $14.4M | $16.2M | $17.9M | $19.6M | $344.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$29.4M | -$44.7M | $34.0M | $84.4M | $9.9M | $47.8M | $120.4M | $148.5M | $191.1M | $277.6M | $304.3M | $330.7M | $383.6M | $385.7M | $381.9M | $360.2M | $381.4M | $400.6M | $420.9M | $448.4M | $468.2M | $499.7M | $285.0M | $294.5M | $101.4M | $109.2M | $110.1M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $109.8M | $44.3M | $98.6M | $191.6M | $71.8M | $53.7M | $26.3M | $35.2M | $94.6M | $58.5M | $71.7M | $166.4M | $336.4M | $332.3M | $284.2M | $209.2M | $221.2M | $165.4M | $183.0M | $146.6M | $105.9M | $293.5M | $57.1M | $69.5M | $26.7M | $30.8M | $96.8M | $47.2M | $50.6M | |||
| Retained Earnings Accumulated Deficit | -$822.2M | -$837.3M | -$798.7M | -$737.5M | -$704.7M | -$658.0M | -$571.9M | -$534.6M | -$494.7M | -$424.1M | -$390.6M | -$358.0M | -$289.2M | -$282.5M | -$282.1M | -$297.6M | -$273.8M | -$252.3M | -$223.8M | -$192.7M | -$168.8M | -$129.7M | -$113.7M | -$100.1M | -$78.2M | -$69.1M | -$66.4M | |||||
| Property Plant And Equipment Net | $1.5M | $1.6M | $1.7M | $1.7M | $1.8M | $2.0M | $2.3M | $2.0M | $2.0M | $2.0M | $2.1M | $2.2M | $2.4M | $2.5M | $1.8M | $1.6M | $1.5M | $1.6M | $1.7M | $1.5M | $1.6M | $1.3M | $1.1M | $659.0K | $513.0K | $543.0K | $569.0K | |||||
| Prepaid Expense And Other Assets Current | $6.0M | $4.8M | $5.3M | $6.4M | $7.5M | $10.7M | $11.7M | $5.9M | $4.5M | $6.3M | $9.6M | $5.9M | $11.8M | $6.5M | $5.5M | $7.5M | $6.6M | $3.6M | $3.6M | $3.8M | $6.1M | $4.0M | $3.8M | $2.2M | $3.1M | $3.9M | $1.7M | |||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Liabilities Current | $38.1M | $35.5M | $44.0M | $43.9M | $40.4M | $32.3M | $39.2M | $41.6M | $35.8M | $21.1M | $19.9M | $19.8M | $20.9M | $20.6M | $14.5M | $24.5M | $20.1M | $23.3M | $29.7M | $30.6M | $24.8M | $20.9M | $16.8M | $14.3M | $11.2M | $10.1M | $8.1M | |||||
| Liabilities And Stockholders Equity | $353.1M | $335.3M | $422.1M | $493.4M | $427.4M | $405.8M | $487.3M | $517.1M | $551.8M | $618.5M | $603.8M | $625.2M | $424.3M | $426.6M | $396.4M | $384.8M | $401.7M | $424.2M | $451.5M | $480.1M | $494.2M | $523.1M | $306.0M | $314.8M | $121.9M | $130.4M | $131.1M | |||||
| Common Stock Value | $28.0K | $28.0K | $30.0K | $30.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $28.0K | $28.0K | $28.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $24.0K | $24.0K | $20.0K | $20.0K | $20.0K | |||||
| Cash And Cash Equivalents At Carrying Value | $109.8M | $44.3M | $98.6M | $191.6M | $71.8M | $53.7M | $26.3M | $35.2M | $94.6M | $58.5M | $71.7M | $166.4M | $336.3M | $332.3M | $284.1M | $209.2M | $221.2M | $165.3M | $182.9M | $146.6M | $105.9M | $293.4M | $57.1M | $69.5M | $26.7M | $30.8M | $96.8M | |||||
| Available For Sale Securities Debt Securities Noncurrent | $7.7M | $28.0M | $43.0M | $27.9M | $42.6M | $15.5M | $40.2M | $59.2M | $94.9M | $147.5M | $130.0M | $91.2M | $15.2M | $5.5M | $7.1M | $36.2M | $14.3M | $50.2M | $23.4M | $45.7M | $68.6M | $18.6M | $32.7M | $61.9M | $999.0K | $13.9M | $20.3M | |||||
| Available For Sale Securities Debt Securities Current | $139.1M | $221.4M | $241.3M | $238.5M | $279.0M | $301.0M | $386.8M | $394.3M | $336.6M | $384.4M | $370.5M | $339.2M | $37.7M | $58.6M | $96.2M | $129.2M | $156.7M | $197.2M | $238.1M | $275.7M | $309.8M | $200.4M | $210.9M | $178.7M | $89.1M | $75.6M | $6.7M | |||||
| Assets Current | $330.7M | $291.9M | $363.1M | $448.7M | $367.4M | $372.4M | $428.0M | $438.5M | $437.2M | $450.4M | $452.8M | $512.4M | $386.6M | $398.1M | $387.1M | $345.8M | $384.5M | $371.1M | $424.6M | $431.0M | $421.9M | $503.0M | $271.8M | $251.9M | $120.3M | $115.8M | $110.2M | |||||
| Assets | $353.1M | $335.3M | $422.1M | $493.4M | $427.4M | $405.8M | $487.3M | $517.1M | $551.8M | $618.5M | $603.8M | $625.2M | $424.3M | $426.6M | $396.4M | $384.8M | $401.7M | $424.2M | $451.5M | $480.1M | $494.2M | $523.1M | $306.0M | $314.8M | $121.9M | $130.4M | $131.1M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $47.0K | -$6.0K | $161.0K | $759.0K | -$415.0K | -$624.0K | -$2.4M | -$3.6M | -$3.3M | -$6.0M | -$3.9M | -$2.4M | -$200.0K | -$176.0K | -$111.0K | $259.0K | $753.0K | $1.1M | $480.0K | $574.0K | $204.0K | -$541.0K | -$677.0K | -$801.0K | -$43.0K | -$59.0K | -$13.0K | |||||
| Accrued Liabilities Current | $33.2M | $30.2M | $36.0M | $38.4M | $33.7M | $25.9M | $30.9M | $35.2M | $31.0M | $16.5M | $16.7M | $15.8M | $14.1M | $16.0M | $11.8M | $18.1M | $12.9M | $13.8M | $15.3M | $14.1M | $8.4M | $7.1M | $4.8M | $4.4M | $3.6M | $3.2M | $4.3M | |||||
| Accounts Payable Current | $2.9M | $3.3M | $6.1M | $3.6M | $4.9M | $4.6M | $6.5M | $4.8M | $3.2M | $3.0M | $1.6M | $2.5M | $5.7M | $4.1M | $2.5M | $5.5M | $6.3M | $8.6M | $10.5M | $10.9M | $9.1M | $6.2M | $4.4M | $2.4M | $2.6M | $3.7M | $2.5M | |||||
| Other Assets Noncurrent | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $258.0K | $258.0K | $477.0K | $1.1M | $1.4M | $1.3M | $1.7M | $1.9M | $2.1M | $79.0K | $322.0K | $289.0K | ||||||||
| Unrealized Gain Loss On Investments | $1.7M | $3.0M | $2.2M | -$161.0K | -$167.0K | $8.0K | $1.0M | $83.0K | ||||||||||||||||||||||||
| Receivables Net Current | $75.7M | $21.4M | $17.9M | $12.2M | $9.0M | $7.1M | $3.3M | $3.2M | $1.5M | $1.2M | $1.0M | $921.0K | $761.0K | $642.0K | $1.2M | $5.0M | $0.00 | $5.0M | $0.00 | $5.0M | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$24.4M | $17.7M | $23.3M | -$329.3M | $33.7M | -$5.7M | ||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $460.0K | $442.0K | $427.0K | $411.0K | $126.0K | |||||||||||||||||||||||||||
| Restricted Cash And Cash Equivalents Noncurrent | $0.00 | $0.00 | $0.00 | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | |||||||||||||||||
| Repayments Of Notes Payable | $0.00 | $1.4M | $1.9M | $1.3M | $0.00 | |||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $13.0M | $13.5M | $13.9M | $14.8M | $15.3M | $15.7M | $16.6M | $17.0M | $17.5M | $18.3M | $18.7M | $19.1M | $19.8M | $20.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $36.1M | $34.0M | $33.2M | $27.4M | $15.3M | $11.5M | $12.4M | $10.0M | $4.4M | $1.2M | $604.0K |
| Payments To Acquire Property Plant And Equipment | $87.0K | $358.0K | $807.0K | $358.0K | $1.4M | $569.0K | $805.0K | $1.1M | $290.0K | $50.0K | $238.0K |
| Payments To Acquire Available For Sale Securities Debt | $196.4M | $380.4M | $303.9M | $802.5M | $118.7M | $194.9M | $251.8M | $347.5M | $290.9M | $0.00 | $0.00 |
| Net Cash Provided By Used In Operating Activities | $19.7M | -$135.3M | -$120.8M | -$73.6M | -$45.9M | -$14.2M | -$69.5M | -$48.5M | -$19.4M | -$9.0M | -$9.7M |
| Net Cash Provided By Used In Investing Activities | $228.0M | $95.4M | $144.8M | -$394.8M | $38.8M | $94.5M | $131.4M | -$142.5M | -$243.1M | -$50.0K | -$238.0K |
| Net Cash Provided By Used In Financing Activities | -$132.6M | $127.1M | -$59.3M | $44.0M | $252.3M | -$879.0K | -$4.5M | $223.4M | $292.5M | $8.6M | $39.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.6M | -$3.2M | $4.2M | $813.0K | $1.8M | -$1.0M | -$3.6M | $5.2M | $1.9M | $1.1M | -$204.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$87.3M | -$33.8M | $10.9M | $9.7M | -$4.7M | -$7.7M | $13.2M | $7.1M | $2.2M | $1.3M | $1.9M |
| Depreciation Depletion And Amortization | $559.0K | $606.0K | $652.0K | $675.0K | $619.0K | $559.0K | $514.0K | $315.0K | $183.0K | $233.0K | $274.0K |
| Proceeds From Sale And Maturity Of Available For Sale Securities | $424.5M | $476.1M | $449.5M | $408.0M | $158.8M | $290.0M | $384.1M | $206.1M | $48.1M | $0.00 | $0.00 |
| Proceeds From Issuance Of Common Stock | $14.3M | $6.5M | $2.5M | $11.8M | $2.6M | $496.0K | $3.0M | $227.5M | $292.5M | $0.00 | $0.00 |
| Increase Decrease In Contract With Customer Asset | -$6.9M | $33.9M | $5.4M | $543.0K | $876.0K | $0.00 | $0.00 | $0.00 | -$1.2M | -$1.0K | |
| Increase Decrease In Operating Lease Liability | -$1.9M | -$1.8M | -$1.6M | -$1.5M | -$72.0K | -$1.2M | -$999.0K | ||||
| Proceeds From Stock Options Exercised | $496.0K | $3.0M | $2.9M | $979.0K | $31.0K | $160.0K | |||||
| Payments For Repurchase Of Common Stock | $68.6M | $456.0K | $50.0M | $0.00 | $0.00 | $0.00 | $0.00 | $1.0K | $0.00 | ||
| Share Based Compensation | $36.1M | $34.0M | $33.2M | $27.4M | $15.3M | $4.4M | $1.2M | $604.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $9.2M | $9.2M | $9.2M | $8.2M | $7.5M | $10.1M | $7.8M | $8.4M | $8.9M | $6.3M | $6.7M | $7.7M | $4.4M | $3.7M | $3.3M | $2.8M | $2.7M | $3.0M | $3.1M | $3.6M | $2.9M | $2.5M | $2.5M | $2.3M | ||
| Payments To Acquire Property Plant And Equipment | $35.0K | $27.0K | $175.0K | $55.0K | $317.0K | $87.0K | $180.0K | $232.0K | $85.0K | $35.0K | ||||||||||||||||
| Payments To Acquire Available For Sale Securities Debt | $122.5M | $59.0M | $48.6M | $322.5M | $6.2M | $74.0M | $79.8M | $32.2M | $27.0M | $0.00 | ||||||||||||||||
| Net Cash Provided By Used In Operating Activities | -$10.7M | -$37.3M | -$24.6M | -$21.0M | -$23.2M | -$15.1M | -$16.1M | -$12.5M | -$8.1M | -$2.1M | ||||||||||||||||
| Net Cash Provided By Used In Investing Activities | $14.8M | $68.6M | $85.4M | -$312.9M | $56.7M | $10.8M | $9.7M | $2.1M | -$27.1M | -$35.0K | ||||||||||||||||
| Net Cash Provided By Used In Financing Activities | -$28.6M | -$13.6M | -$37.6M | $4.6M | $167.0K | -$1.3M | -$1.3M | -$1.4M | $80.7M | -$275.0K | ||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$530.0K | $1.6M | -$51.0K | $1.2M | $2.4M | -$233.0K | $1.2M | -$388.0K | $143.0K | $316.0K | ||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$24.0M | -$5.2M | $8.5M | $3.5M | -$5.0M | -$5.2M | $5.1M | -$158.0K | $682.0K | -$1.1M | ||||||||||||||||
| Depreciation Depletion And Amortization | $146.0K | $163.0K | $166.0K | $162.0K | $125.0K | $140.0K | $115.0K | $54.0K | $39.0K | $57.0K | ||||||||||||||||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $137.4M | $127.6M | $134.1M | $9.6M | $63.3M | $84.9M | $89.6M | $34.6M | $0.00 | |||||||||||||||||
| Proceeds From Issuance Of Common Stock | $290.0K | $811.0K | $1.3M | $4.8M | $167.0K | $0.00 | $80.2M | |||||||||||||||||||
| Increase Decrease In Contract With Customer Asset | -$22.9M | $238.0K | $104.0K | $45.0K | $1.2M | $5.0M | $0.00 | |||||||||||||||||||
| Increase Decrease In Operating Lease Liability | -$462.0K | -$426.0K | -$391.0K | -$359.0K | -$145.0K | |||||||||||||||||||||
| Proceeds From Stock Options Exercised | $167.0K | $36.0K | $574.0K | $72.0K | $355.0K | $9.0K | ||||||||||||||||||||
| Payments For Repurchase Of Common Stock | $4.4M | $0.00 | $37.5M | $0.00 | $0.00 | $1.0K | ||||||||||||||||||||
| Share Based Compensation | $9.2M | $10.1M | $8.9M | $7.7M | $3.3M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.46 | -$5.12 | -$6.08 | -$4.57 | -$2.11 | -$0.73 | -$3.60 | -$2.50 | -$1.52 | -$1.62 | -$2.12 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0K | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Shares Outstanding | 28.0M | 30.5M | 26.6M | 28.5M | 27.6M | 27.4M | 27.3M | 26.9M | 23.8M | 2.7M | |
| Common Stock Shares Issued | 28.0M | 30.5M | 26.6M | 28.5M | 27.6M | 27.4M | 27.3M | 26.9M | 23.8M | 2.7M | |
| Weighted Average Number Of Shares Outstanding Basic | 28.8M | 28.4M | 26.9M | 28.2M | 27.4M | 27.3M | 27.1M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 28.8M | 28.4M | 26.9M | 28.2M | 27.4M | 27.3M | 27.1M | ||||
| Earnings Per Share Basic | $-0.46 | $-5.12 | $-6.08 | $-4.57 | $-2.11 | $-0.73 | $-3.60 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 27.3M | 27.1M | 24.7M | 19.8M | 2.6M | 2.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.52 | -$1.34 | -$1.28 | -$1.14 | -$1.71 | -$1.64 | -$1.41 | -$1.50 | -$1.58 | -$1.18 | -$1.15 | -$1.31 | -$0.24 | -$0.02 | -$0.66 | -$0.87 | -$0.79 | -$0.30 | -$1.15 | -$0.89 | -$0.82 | -$0.66 | -$0.57 | -$0.63 | -$0.45 | -$0.13 | -$0.75 | -$0.42 | $0.05 | -$0.34 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 60.0M | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 11.5M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Common Stock Shares Outstanding | 27.6M | 28.0M | 30.4M | 30.4M | 27.4M | 27.3M | 26.6M | 26.5M | 27.0M | 28.4M | 28.2M | 28.2M | 27.5M | 27.4M | 27.4M | 27.3M | 27.3M | 27.3M | 27.1M | 27.0M | 27.0M | 26.7M | 24.0M | 23.8M | 20.5M | 20.3M | 20.2M | ||||
| Common Stock Shares Issued | 27.6M | 28.0M | 30.4M | 30.4M | 27.4M | 27.3M | 26.6M | 26.5M | 27.0M | 28.4M | 28.2M | 28.2M | 27.5M | 27.4M | 27.4M | 27.3M | 27.3M | 27.3M | 27.1M | 27.0M | 27.0M | 26.7M | 24.0M | 23.8M | 20.5M | 20.3M | 20.2M | ||||
| Weighted Average Number Of Shares Outstanding Basic | 27.8M | 28.8M | 30.6M | 28.9M | 27.4M | 26.8M | 26.5M | 26.6M | 28.0M | 28.3M | 28.2M | 27.7M | 27.4M | 27.4M | 27.4M | 27.3M | 27.3M | 20.4M | 20.3M | 2.6M | 2.6M | ||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 29.0M | 28.8M | 30.6M | 28.9M | 27.4M | 26.8M | 26.5M | 26.6M | 28.0M | 28.3M | 28.2M | 27.7M | 27.4M | 27.4M | 27.4M | 27.3M | 27.3M | 20.4M | 20.3M | 2.6M | 3.5M | ||||||||||
| Earnings Per Share Basic | $0.54 | $-1.34 | $-1.28 | $-1.14 | $-1.71 | $-1.64 | $-1.41 | $-1.50 | $-1.58 | $-1.18 | $-1.15 | $-1.31 | $-0.24 | $-0.02 | $-0.66 | $-0.87 | $-0.79 | $-0.45 | $-0.13 | $-0.42 | $0.07 | ||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 27.4M | 27.3M | 27.3M | 27.3M | 27.1M | 27.0M | 27.0M | 24.1M | 23.9M | 23.8M | 20.4M | 20.3M | 15.3M | 2.6M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $7.0K | $8.0K | $154.0K | $31.0K | $279.0K | $41.0K | $159.0K | $191.0K | $104.0K | $11.0K |
| Additional Paid In Capital | $809.8M | $829.9M | $703.0M | $717.8M | $678.6M | $660.7M | $648.7M | $633.3M | $393.0M | $16.7M | |
| Sharebased Compensation And Issuance Of Stock And Warrants For Services Or Claims | $27.4M | $15.3M | $11.5M | $12.4M | $10.0M | $4.4M | $1.2M | ||||
| Interest Income Other | $13.5M | $19.8M | $18.9M | $7.6M | $431.0K | $4.0M | $11.0M | $6.7M | $1.6M | $127.0K | |
| Other Noncash Income Expense | -$18.1M | -$21.1M | -$1.5M | $0.00 | -$676.0K | -$646.0K | -$619.0K | -$105.0K | -$110.0K | ||
| Stock Issued During Period Value Stock Options Exercised | $11.9M | $2.6M | $497.0K | $3.0M | $2.9M | $979.0K | $31.0K | $160.0K | |||
| Stock Issued During Period Value Options And Employee Stock Purchase Plan | $14.3M | $6.5M | $2.4M | $11.9M | $2.6M | ||||||
| Interest Paid Net | $80.0M | $42.1M | $0.00 | $0.00 | $0.00 | $4.0K | $424.0K | $1.0M | $1.1M | $354.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditures Incurred But Not Yet Paid | $11.0K | $0.00 | $38.0K | $19.0K | $58.0K | $86.0K | $233.0K | $7.0K | $52.0K | $7.0K | ||||||||||||||||||||
| Additional Paid In Capital | $792.7M | $792.5M | $832.5M | $821.1M | $715.0M | $706.4M | $694.6M | $686.6M | $689.1M | $707.7M | $698.7M | $691.2M | $673.0M | $668.4M | $664.1M | $657.6M | $654.5M | $651.7M | $644.1M | $640.6M | $636.7M | $629.9M | $399.4M | $395.4M | $179.6M | $178.3M | $176.5M | |||
| Sharebased Compensation And Issuance Of Stock And Warrants For Services Or Claims | $4.4M | $3.7M | $3.3M | $2.8M | $2.7M | $3.0M | $3.1M | $3.6M | $2.9M | $2.5M | $2.5M | $2.3M | $942.0K | $1.4M | $866.0K | $255.0K | $295.0K | $322.0K | ||||||||||||
| Interest Income Other | $2.9M | $3.7M | $4.4M | $5.3M | $4.6M | $4.6M | $4.9M | $4.7M | $4.5M | $2.3M | $1.1M | $342.0K | $64.0K | $104.0K | $195.0K | |||||||||||||||
| Other Noncash Income Expense | -$18.1M | -$6.3M | -$4.3M | -$4.9M | $0.00 | $0.00 | -$164.0K | -$156.0K | -$150.0K | -$22.0K | ||||||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $2.7M | $203.0K | $592.0K | $167.0K | $263.0K | $71.0K | $36.0K | $454.0K | $215.0K | $574.0K | $669.0K | $1.4M | $72.0K | |||||||||||||||||
| Stock Issued During Period Value Options And Employee Stock Purchase Plan | $788.0K | $1.4M | $290.0K | $4.1M | $1.0M | $811.0K | $160.0K | $775.0K | $1.2M | $2.7M | $882.0K | $4.8M | ||||||||||||||||||
| Interest Paid Net | $18.1M | $0.00 | $0.00 | $4.0K | $172.0K | $297.0K |
Most recent annual filing with the SEC: March 3, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.